Clinical characteristics of initial recurrence in lung after surgical resection for pancreatic ductal adenocarcinoma

Pancreatology. 2020 Oct;20(7):1472-1478. doi: 10.1016/j.pan.2020.08.019. Epub 2020 Aug 27.

Abstract

Background: The clinical characteristic differences at the initial recurrence site after resection for pancreatic ductal adenocarcinoma (PDAC) remain unknown. We investigated the clinical characteristics in patients with lung recurrence after surgical resection and evaluated the outcome of resection for isolated lung recurrence.

Methods: Of 442 consecutive PDAC patients who underwent surgical resection between 2002 and 2018, 229 had recurrence on imaging. Initial recurrence sites were the liver, lung, local, peritoneal, multiple organs, and others. We analyzed the clinicopathologic factors and outcomes, comparing by initial recurrence site, and investigated the outcomes of resection for isolated lung recurrence.

Results: Liver recurrences were the most frequent (n = 60, 26%), followed by lung recurrence (n = 48, 21%). The interval from surgery to recurrence was significantly longer in lung recurrence (P = 0.0001). Patients with lung recurrence had significantly longer overall survival after diagnosis (P < 0.0001). Patients who underwent surgical resection of lung recurrence had a significantly prolonged overall survival rate after recurrence diagnosis (P = 0.004).

Conclusions: Patients with lung recurrence had significantly prolonged survival than those with other recurrence patterns. Resection for isolated lung recurrence represented relatively good prognosis, and possibly may be beneficial in highly-selected patients.

Keywords: Lung; Lung recurrence; Pancreatic cancer; Pancreatic ductal adenocarcinoma; Pulmonary metastasis.

MeSH terms

  • Aged
  • CA-19-9 Antigen / analysis
  • Carcinoma, Pancreatic Ductal / pathology*
  • Carcinoma, Pancreatic Ductal / surgery
  • Cohort Studies
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Liver Neoplasms / epidemiology
  • Liver Neoplasms / secondary
  • Lung Neoplasms / epidemiology
  • Lung Neoplasms / secondary*
  • Lung Neoplasms / surgery
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Pancreatectomy
  • Pancreatic Neoplasms / pathology*
  • Pancreatic Neoplasms / surgery
  • Prognosis
  • Retrospective Studies
  • Survival Analysis
  • Treatment Outcome

Substances

  • CA-19-9 Antigen